RCT on the Performance and Safety of LightForce® Therapy Lasers on Knee Osteoarthritis Pain Reduction (SPARK)

Exclusion Criteria

• •Patient with musculoskeletal pathological conditions not to be treated with/contraindication to the use of LightForce® Therapy Lasers according to its intended use and indications
• •Patients who are taking drugs that have heat or light sensitive contraindications, such as but not limited to certain types of steroids
• •Patients who are administered with corticosteroids, should discontinue the treatment at least 2 weeks prior to study treatment start
• •Pregnant females or females of childbearing potentially planning to become pregnant during the study participation
• •Patients who had inflammatory arthritis (i.e. rheumatoid arthritis, psoriatic arthritis)
• •Patients who underwent intra-articular injection (Ialuronic acid, platelet rich plasma or corticosteroids) in the knee in the last 6 months
• •Patients who have a disease that would limit their participation in exercises (i.e. severe chronic obstructive pulmonary disease, severe heart failure, cerebrovascular event history)
• •Patients who have hip or ankle/foot joint pathology that might interfere with participation in exercises/knee recovery
• •Patients with a diagnosis of active cancer
• •Patients with tattoos covering more than 30% of the area to be treated with LightForce® Therapy Lasers
• •Patients who are mentally or physically incapacitated
• •Patient participating in other clinical study or has completed a clinical study less than 30 days prior to enrollment
• •Patients with other musculoskeletal problems of the knee joint such as tendon or ligament injury, recent surgery, recent fracture, or recent meniscus injury and/or undergoing to specific physiotherapy for these ("recent" is defined as within 30 days prior to enrollment)
• •Patients with other clinically significant co-morbidities that make the patient unsuitable for study participation, at the discretion of the investigator.